Antenatal Syphilis Burden, Risk Factors and Pregnancy Outcomes in a High HIV Prevalence Setting

Authors

  • Kerina Duri Author
  • Privilege Tendai Munjoma Author
  • Hope Mataramvura Author
  • Arthur John Mazhandu Author
  • Panashe Chandiwana Author
  • Felicity Zvanyadza Gumbo Author
  • Asaph Ziruma Author

Keywords:

sexually-transmitted infections; treponemal and non-treponemal testing in parallel, traditional and reverse algorithms; pregnancy during the era of lifelong antiretroviral therapy; syphilis and HIV coinfection synergies; resourcelimited settings

Abstract

Syphilis in pregnancy remains an important preventable cause of perinatal mortality and morbidity, yet
the respective modifiable factors remain inadequately described in resource-limited settings where
syphilis and HIV infections have significant epidemic synergies. The study aimed to determine the
burden of syphilis in HIV-uninfected and HIV-infected pregnant women during this era of lifelong
antiretroviral therapy. This study was based on a prospective cohort of pregnant women ≥20 weeks’
gestational age seeking antenatal care services at four primary healthcare facilities in Harare. A
flocculation non-treponemal test (NTT) and rapid chromatographic treponemal test (TT) were run in
parallel on fresh maternal sera. Confirmation was done using either the traditional algorithm (TA) or
reverse algorithm (RA). TA is whereby a positive NTT result is confirmed with a TT, whilst in RA, a
positive TT is followed by a NTT. Discordant test results were resolved using a second, but different
TT. Adverse infant outcomes were assessed at delivery. Six hundred HIV-uninfected and 608 HIVinfected
pregnant women mainly on Tenofovir/Lamivudine/Efavirenz were enrolled. The presence of
syphilis antibodies, regardless of whether active or past infection, was 53/1208:4.39%, 95% confidence
interval (CI) [3.2-5.6]; being 38/608:6.25%,95%CI[4.4-8.2] and 15/600:2.50%, 95%CI[1.3-3.7] in
the HIV-infected and HIV-uninfected women, respectively. Prevalence of active syphilis (AS) was
25/1208:2.07%, 95%CI [1.3-2.9], disproportionately occurring in the HIV-infected; 19/25(76%) versus
6/25(24%) in their HIV-uninfected peers, p=0.024. In a regression model with variable elimination, the
absence of anaemia was protective, odds ratio (CI):6.2(1.5-42.6), p=0.027. Infants exposed to AS in
pregnancy had lower birth weights; median (interquartile range) 3000g (2700-3192) versus 3200g
(2950-3400) in the unexposed, p=0.014. High and moderate syphilis burdens were observed in HIVinfected
and HIV-uninfected pregnant women, respectively. This underscores the need to further
strengthen the current sexually-transmitted infections prevention and care programmes, especially in
HIV-infected women of reproductive age, if the 2030 Sustainable Development Goal target 3.2 is to
be met (www.clinicaltrials.gov,trialregistrationnumber:NCT04087239).

Downloads

Published

2024-12-31